enGene Holdings Inc.
ENGNNASDAQHealthcare● Active
$1.65
+$0.01(+0.61%)
Market Cap$84471712
P/E Ratio—
52W High$12.25
52W Low$1.4
enGene Holdings Inc. (ENGN) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ENGN · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2026Report Date: Mar 9, 2026EPS Actual
-$0.44
Est. -$0.55 · +20.0%
Revenue
—
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Mar 9, 2026
After Market Close
▲ Beat EPS✓ 1-Quarter EPS Beat Streak
ENGN reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.72B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.72B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | Jun 11, 2026 | -$0.48 | — | — | — | — | — |
| ▲ Q1 FY2026 | Mar 9, 2026 | -$0.55 | -$0.44 | +20.0% | — | — | — |
| ▼ Q4 FY2025 | Dec 22, 2025 | -$0.57 | -$0.73 | -28.8% | — | — | — |
| ▼ Q3 FY2025 | Sep 11, 2025 | -$0.50 | -$0.57 | -14.5% | — | — | — |
| ▼ Q2 FY2025 | Jun 12, 2025 | -$0.50 | -$0.51 | -2.6% | — | — | — |
| ▼ Q1 FY2025 | Mar 10, 2025 | -$0.37 | -$0.48 | -30.5% | — | — | — |
| ▲ Q4 FY2024 | Dec 19, 2024 | -$0.40 | -$0.34 | +14.1% | $0.00B | — | — |
| ▲ Q3 FY2024 | Sep 10, 2024 | -$0.37 | -$0.32 | +13.5% | — | — | — |
Q2 FY2026
Jun 11, 2026
EPS Actual
—
EPS Est.
-$0.48
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 9, 2026Beat
EPS Actual
-$0.44
EPS Est.
-$0.55
EPS Surpr.
+20.0%
Revenue
—
Q4 FY2025
Dec 22, 2025Miss
EPS Actual
-$0.73
EPS Est.
-$0.57
EPS Surpr.
-28.8%
Revenue
—
Q3 FY2025
Sep 11, 2025Miss
EPS Actual
-$0.57
EPS Est.
-$0.50
EPS Surpr.
-14.5%
Revenue
—
Q2 FY2025
Jun 12, 2025Miss
EPS Actual
-$0.51
EPS Est.
-$0.50
EPS Surpr.
-2.6%
Revenue
—
Q1 FY2025
Mar 10, 2025Miss
EPS Actual
-$0.48
EPS Est.
-$0.37
EPS Surpr.
-30.5%
Revenue
—
Q4 FY2024
Dec 19, 2024Beat
EPS Actual
-$0.34
EPS Est.
-$0.40
EPS Surpr.
+14.1%
Revenue
$0.00B
Q3 FY2024
Sep 10, 2024Beat
EPS Actual
-$0.32
EPS Est.
-$0.37
EPS Surpr.
+13.5%
Revenue
—
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $-0.18 | $-0.18 | $-0.18 | 3 |
| Q3 FY2028 | $-0.18 | $-0.18 | $-0.18 | 3 |
| Q2 FY2028 | $-0.18 | $-0.18 | $-0.18 | 3 |
| Q1 FY2028 | $-0.51 | $-0.51 | $-0.51 | 4 |
| Q4 FY2027 | $-0.51 | $-0.51 | $-0.51 | 3 |
| Q3 FY2027 | $-0.51 | $-0.51 | $-0.51 | 4 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q1 FY2026 | Mar 9, 2026 | +20.0% | $8.68 | $7.05 | -18.78% |
| ▼ Q4 FY2025 | Dec 22, 2025 | -28.8% | $8.69 | $8.77 | +0.92% |
| ▼ Q3 FY2025 | Sep 11, 2025 | -14.5% | $6.29 | $6.06 | -3.66% |
| ▼ Q2 FY2025 | Jun 12, 2025 | -2.6% | $3.22 | $3.25 | +0.93% |
| ▼ Q1 FY2025 | Mar 10, 2025 | -30.5% | $5.25 | $5.24 | -0.19% |
| ▲ Q4 FY2024 | Dec 19, 2024 | +14.1% | $5.93 | $5.96 | +0.51% |
| ▲ Q3 FY2024 | Sep 10, 2024 | +13.5% | $6.58 | $6.50 | -1.22% |
| ▼ Q2 FY2024 | Jun 14, 2024 | -46.1% | $10.00 | $9.00 | -10.00% |
Q1 FY2026-18.78%
Report Date
Mar 9, 2026
EPS Beat/Miss
+20.0%
Price Before
$8.68
Price After
$7.05
Q4 FY2025+0.92%
Report Date
Dec 22, 2025
EPS Beat/Miss
-28.8%
Price Before
$8.69
Price After
$8.77
Q3 FY2025-3.66%
Report Date
Sep 11, 2025
EPS Beat/Miss
-14.5%
Price Before
$6.29
Price After
$6.06
Q2 FY2025+0.93%
Report Date
Jun 12, 2025
EPS Beat/Miss
-2.6%
Price Before
$3.22
Price After
$3.25
Q1 FY2025-0.19%
Report Date
Mar 10, 2025
EPS Beat/Miss
-30.5%
Price Before
$5.25
Price After
$5.24
Q4 FY2024+0.51%
Report Date
Dec 19, 2024
EPS Beat/Miss
+14.1%
Price Before
$5.93
Price After
$5.96
Q3 FY2024-1.22%
Report Date
Sep 10, 2024
EPS Beat/Miss
+13.5%
Price Before
$6.58
Price After
$6.50
Q2 FY2024-10.00%
Report Date
Jun 14, 2024
EPS Beat/Miss
-46.1%
Price Before
$10.00
Price After
$9.00
Avg Beat Reaction-6.50%
Avg Miss Reaction-2.40%
Beat Rate3 / 8 quarters
Largest Move-18.78% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ENGN ends December
enGene Holdings Inc. (ENGN) most recently reported earnings on March 9, 2026 for Q1 FY2026, posting EPS of $-0.44 — beating the analyst consensus of $-0.55 by +20.0%. The next ENGN earnings date is expected around September 1, 2026.
Each quarter, investors track ENGN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ENGN revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ENGN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ENGN earnings · 5 questionsenGene Holdings Inc.'s next earnings report is expected around September 1, 2026. ENGN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ENGN historically reports after market close (AMC).
ENGN earnings datewhen is ENGN earningsENGN next earnings datewhen does ENGN report earningsENGN earnings calendar
▸ Source: FMP · enGene Holdings Inc. SEC filings · US GAAP · enGene Holdings Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026